RXRX Recursion Pharmaceuticals Inc Total Debt to Capital

RXRX (Recursion Pharmaceuticals Inc) - company brandmark

The AI-driven drug discovery market is characterized by fierce competition and pressure from global tech giants. The share price trend for Recursion Pharmaceuticals (RXRX) reflects the position of a biotech leader developing advanced digital cell mapping systems. However, the individual debt-to-equity ratio stands at 0.07, highlighting a lack of profitability and a high dependence on supercomputing expenditures.

RXRX Recursion Corp All Debt to Shareholders' Equity Ratio (07/04/2022 - 10/27/2026)

Analytical breakdowns for Recursion Pharmaceuticals

- price and consensus price forecast:
Stock Price recursion.com|RXRX - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Recursion|RXRX - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Recursion|RXRX - Accounting Value of Company|Market Capitalization to Book Value Ratio recursion.com|RXRX - Company Assets
- debt and liquidity data:
Total Debt to Capital Recursion Pharmaceuticals|RXRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Recursion Pharmaceuticals Inc|RXRX - Company Aggregate Debts|Debt to Book Capitalization Ratio Recursion
Summary company analysis:RXRX - Recursion Corp
Brand item of Recursion Pharma

This ratio determines the degree of the business's dependence on borrowed funds relative to equity, measuring bankruptcy risk and the issuer's overall financial autonomy. An analysis of the financial risk metric (debt-to-equity) confirms that investments in the AI ecosystem and laboratory automation of Recursion Pharmaceuticals (RXRX) require a precise leverage balance to maintain the pace of technological scaling without compromising the stability of the capital structure.

Key competitors

NVDA (NVIDIA) - Total Debt to Capital|Total Debt to Capital CoreWeave, Inc.|NBIS (Nebius) - Total Debt to Capital|Total Debt to Capital Coefficient SOUN (SoundHound Corp)|Debt to Equity Zeta Global Corp|All Debt to Shareholders' Equity Ratio pagaya.com PGY|AI (C3.ai Corp) - Total Debt to Capital|RZLV - Debt to Capital|SUPX (Super X AI Corp) - Total Debt to Capital|Total Debt to Equity Ratio Ginkgo Bioworks Holdings, Inc.|CRNC (Cerence Inc.) - Total Debt to Equity Ratio|Total Debt to Capital PDYN|Veritone, Inc. (VERI) - Debt to Equity|All Debt to Shareholders' Equity Ratio MIMI (mimintinc.com)|Debt to Equity MLGO|Total Debt to Capital Coefficient Helport AI Ltd. HPAI|Total Debt to Capital LPSN (LivePerson, Inc.)|QUIK: Total Debt to Capital Coefficient|Debt to Equity SST|DVLT (Datavault AI Inc.) - Debt to Capital|Debt to Equity Ruanyun Edai Tech (RYET)|Debt to Equity Ratio Wetour (WETO)|Micropolis Holding (MCRP) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio CYN (cyngn.com)|Connexa Sports Technologies Inc. (YYAI) - Debt to Equity|Aggregate Debt to Equity MicroCloud Hologram, Inc. HOLO|Total Debt to Capital MultiSensor AI Holdings (MSAI)|EVAX - All Debt to Shareholders' Equity Ratio|AIXI: Total Debt to Capital|CXAI (cxapp.com) - Total Debt to Capital|BNAI - Debt to Equity|All Debt to Shareholders' Equity Ratio GXAI|Debt to Equity EVGN (Evogene Ltd.)|Total Debt to Equity Ratio infobird.com (IFBD)|Total Debt to Capital TAOP (Taoping Inc.)|Total Debt to Capital VERSES AI Inc. VSAI|EXAI: Total Debt to Capital|FOXO - Total Debt to Equity Ratio|Total Debt to Capital VHAI|Debt to Capital Zapata Computing Holdings Inc.